News
So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
U.S. Health Secretary Robert F. Kennedy Jr’s newly appointed Advisory Committee on Immunization Practices (ACIP) upheld ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results